Skip to main content
logo
Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.390
-0.010 (-0.44%)
Aug 12, 2026, 11:43 AM EDT - Market open

Aytu BioPharma Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
56.666.3865.18107.496.6765.63
Revenue Growth
-14.04%1.84%-39.31%11.10%47.29%137.52%
Gross Profit
36.6645.8349.0566.6352.2829.2
Operating Income
-4.06-7.83-1.59-17.07-109.91-58.87
Net Income
-34.06-13.56-15.84-17.05-108.78-58.29
Earnings Per Share
-4.58-2.16-2.86-5.11-74.01-69.60
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
26.7230.9520.0122.9919.3649.65
Total Debt
21.8221.8215.1316.3618.1924.78
Net Cash (Debt)
4.99.144.886.621.1724.87
Net Cash Growth
-87.35%-26.37%465.19%-95.29%-46.03%
Net Cash Per Share
0.421.450.881.980.8029.70

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
1.68-1.94-1.39-5.13-28.82-25.96
Capital Expenditures
-0.03-0.23-0.33---
Free Cash Flow
1.64-2.17-1.72-5.13-28.82-25.96
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
64.78%69.04%75.26%62.04%54.08%44.49%
Operating Margin
-7.18%-11.79%-2.44%-15.89%-113.69%-89.70%
Pretax Margin
-59.49%-20.71%-15.92%-15.88%-112.64%-88.42%
Profit Margin
-60.28%-21.36%-19.21%-15.88%-112.53%-88.81%
FCF Margin
2.90%-3.26%-2.63%-4.78%-29.82%-39.56%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Forward PE
-9.03----
PS Ratio
0.460.290.270.080.282.10